NCT04305444 2025-01-08
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
Zhejiang DTRM Biopharma
Phase 2 Terminated
Clinical Trials
6 trialsNCT00702052 2021-05-25
PILLAR-1
Novartis
Phase 2 Completed
NCT00436618 2019-10-22
Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Mayo Clinic
Phase 2 Completed
NCT01022996 2016-05-18
Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.
Novartis
Phase 2 Completed
NCT00516412 2015-09-29
Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Swiss Cancer Institute
Phase 2 Completed
NCT00727207 2012-12-17
Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy
Technical University of Munich
Phase 2 Terminated